This HTML5 document contains 117 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q86328955
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2014 scientific article published on 18 December 2014 artículu científicu espublizáu n'avientu de 2014 im Dezember 2014 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в грудні 2014 wetenschappelijk artikel
p:P577
wds:Q86328955-E8D97C17-9F2B-492A-9E10-3F5ED4ACC349
wdt:P577
2014-12-18T00:00:00Z
p:P2888
wds:Q86328955-D0425F94-31E2-4196-85FA-11D7DC90AE42
wdt:P2888
n13:s12032-014-0443-4
p:P2860
wds:Q86328955-36A23DC8-2FC1-4884-B5ED-AC789DD81CB1 wds:Q86328955-3762B83D-D02F-4063-8660-BCE52AAD468E wds:Q86328955-396894EA-7B66-4FD5-94B5-29B0910C62B3 wds:Q86328955-3F0205E1-1424-40B2-896E-D500DC7F95D8 wds:Q86328955-531373A7-8BEE-4471-AE5E-2BBEBCAF0262 wds:Q86328955-65B86069-E8E4-4987-ABAA-679B1D71A2A4 wds:Q86328955-6CD6D3BE-CD0A-4AC0-9FAD-FF6DD5767B24 wds:Q86328955-70BF08C5-D084-4A7C-A4F2-D5D7F9C2ABFF wds:Q86328955-731C90C5-A135-4F49-B6A3-82B68F2B1447 wds:Q86328955-79C6FA99-2160-4790-9B7B-EDFFEA0A507B wds:Q86328955-7BFF4D8C-D086-4393-8BF7-4669AE34144A wds:Q86328955-8F3254B2-D28E-4E44-AF06-AABB1E425086 wds:Q86328955-90B599FC-9B74-4E83-BBE1-5B908F1039C0 wds:Q86328955-953F3BAA-DF9D-4132-9AD2-F0A5F8FACB45 wds:Q86328955-9A42EDFB-9437-4038-AD1A-91E20AD1BA54 wds:Q86328955-A8ED3619-5644-48AD-89A4-01EB8A80160F wds:Q86328955-B791595F-7573-443E-963D-794738BF1496 wds:Q86328955-C25498A4-01C0-4A20-B7DC-4C2B9A9EE21E wds:Q86328955-CF49B09E-D353-4619-ADBA-E48D98A55686 wds:Q86328955-E5CA7EC5-7C7E-47BE-81F3-304496821393 wds:Q86328955-F00B059E-C14C-4961-86CF-25BA60DF7662 wds:Q86328955-F2E12598-AB54-4581-A920-D72C1D404518 wds:Q86328955-082859A3-A15B-4A87-A228-55B645029CF8 wds:Q86328955-08889798-8B1D-4688-9AAE-2D4AAB39AC45 wds:Q86328955-0D1E045A-9D9B-4263-A040-FC68355FE34F wds:Q86328955-119C1662-32A5-415C-A2CD-5878FFA62899 wds:Q86328955-1A22A1D2-C164-4892-9812-651BBEC7F641 wds:Q86328955-1BEF385C-48DE-4441-B91C-53861AFC7270 wds:Q86328955-1ED846DA-0460-438C-826F-0AD347A2F922 wds:Q86328955-300209B3-BBA6-4C97-8FF0-24D8DD079F9B wds:Q86328955-30D4DD4E-8465-42AD-A4D3-D63DF0434B36 wds:Q86328955-3566B5E4-7093-45A1-9A4A-43108BA16D3B
wdt:P2860
wd:Q29620155 wd:Q33767866 wd:Q37763502 wd:Q34887495 wd:Q46830983 wd:Q34432972 wd:Q33397990 wd:Q57220173 wd:Q42841495 wd:Q37833263 wd:Q29617512 wd:Q33416977 wd:Q79134572 wd:Q34975572 wd:Q45182740 wd:Q43897080 wd:Q29617472 wd:Q38023842 wd:Q27860648 wd:Q45947144 wd:Q40238593 wd:Q35788112 wd:Q28376841 wd:Q73251649 wd:Q40591372 wd:Q36442804 wd:Q27860595 wd:Q38103647 wd:Q53970403 wd:Q45950526 wd:Q29617511 wd:Q27861047
p:P2093
wds:Q86328955-18C1538D-318F-4207-860B-06E939BB52BF wds:Q86328955-BFAC7285-EAD9-4414-8737-12E2B3C11EFD wds:Q86328955-A065864E-0C07-4878-A498-37DE241DFCAE wds:Q86328955-91AAE020-A230-4449-8BAC-83B4A6F20D89 wds:Q86328955-3A134A5A-6EF9-4DE5-A429-D9C4C6F76763
wdt:P2093
Ariel Galapo Kann Karla Teixeira Souza Ana Carolina Ribeiro Chaves Carlos Dzik Leonardo Gomes da Fonseca
rdfs:label
Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
skos:prefLabel
Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
schema:name
Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
p:P50
wds:Q86328955-46228910-E636-4754-A471-C0CF07B6FE76 wds:Q86328955-B4ACFB51-A137-48EA-86BE-180759C604AE
wdt:P50
wd:Q80423963 wd:Q62743897
p:P1476
wds:Q86328955-FDF53E17-5B32-48AF-A67C-4109F88EBBA4
wdt:P1476
Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer
p:P304
wds:Q86328955-73158495-42E8-4563-B4E7-F8A48E79F126
wdt:P304
443
p:P31
wds:Q86328955-63EF3FC2-ABB9-4D0D-9155-8F20E959F689
wdt:P31
wd:Q13442814
p:P921
wds:Q86328955-85E3994E-0E3C-4EE3-9EEE-B6A11BD02363
wdt:P921
wd:Q181257
p:P698
wds:Q86328955-35C64706-9BE6-4A80-A1D9-683FB5A61401
wdtn:P698
n12:25519824
wdt:P698
25519824
p:P1433
wds:Q86328955-1FD040CC-B7AE-4697-A13F-B1A5D2619BCE
wdt:P1433
wd:Q2152666
p:P433
wds:Q86328955-A85FE14F-21B8-470E-922F-63B09518C829
p:P478
wds:Q86328955-12D83703-A4C1-4FB0-A116-D85220F0BBA4
wdt:P433
1
wdt:P478
32
p:P356
wds:Q86328955-20322D35-9F2D-425F-AE94-F2DF20EC75E5
wdtn:P356
n9:S12032-014-0443-4
wdt:P356
10.1007/S12032-014-0443-4
p:P6179
wds:Q86328955-FA00D2D2-2D1D-423E-9509-2B7776355B3A
wdt:P6179
1049880259